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Abstract.
Background: A key focus for dementia risk-reduction is the prevention of socio-demographic, lifestyle, and nutritional
risk factors. High sodium intake is associated with hypertension and cardiovascular disease (both are linked to dementia),
generating numerous recommendations for salt reduction to improve cardiovascular health.
Objective:This systematic review aimed to assess, in middle- and older-aged people, the relationship between dietary sodium
intake and cognitive outcomes including cognitive function, risk of cognitive decline, or dementia.
Methods: Six databases (PubMed, EMBASE, CINAHL, Psych info, Web of Science, and Cochrane Library) were searched
from inception to 1 March 2020. Data extraction included information on study design, population characteristics, sodium
reduction strategy (trials) or assessment of dietary sodium intake (observational studies), measurement of cognitive function
or dementia, and summary of main results. Risk-of-bias assessments were performed using the National Heart, Lung, and
Blood Institute (NHLBI) assessment tool.
Results: Fifteen studies met the inclusion criteria including one clinical trial, six cohorts, and eight cross-sectional studies.
Studies reported mixed associations between sodium levels and cognition. Results from the only clinical trial showed that
a lower sodium intake was associated with improved cognition over six months. In analysis restricted to only high-quality
studies, three out of four studies found that higher sodium intake was associated with impaired cognitive function.
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∗Correspondence to: Devi Mohan, Senior Lecturer in Global
Public Health, Jeffrey Cheah School of Medicine and Health
Sciences, Monash University Malaysia, Jalan Lagoon Selatan,
47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia. Tel.:
+603 5515 9658; E-mail: devi.mohan@monash.edu.
ISSN 1387-2877/20/$35.00 © 2020 – IOS Press and the authors. All rights reserved
This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC 4.0).
1348 D. Mohan et al. / Sodium Intake and Cognitive Outcomes
Conclusion: There is some evidence that high salt intake is associated with poor cognition. However, findings are mixed,
likely due to poor methodological quality, and heterogeneous dietary, analytical, and cognitive assessment methods and
design of the studies. Reduced sodium intake may be a potential target for intervention. High quality prospective studies and
clinical trials are needed.
Keywords: Cognitive dysfunction, dementia, salt, sodium, systematic review
INTRODUCTION
Dementia is a severe condition characterized by
cognitive deficits and loss of independence. It is asso-
ciated with a wide range of poor outcomes including
increased frailty and mortality [1–4]. Aging is one
of the most important risk factors for cognitive
decline and dementia and the rapid shifts in global
demographic trends are contributing to the projected
increase in dementia cases over the next decades [5].
Currently, dementia is incurable and pharmacolog-
ical treatments for symptom management are modest
[6]. There have been numerous calls for research
directed at the identification and testing of preven-
tative strategies to minimize, or arrest the onset of
cognitive decline and reduce the rate of conversion
to clinical dementia in high risk individuals [7].
Observational studies suggests that in some cases the
pathological processes underlying dementia might
be influenced by dietary components [8]. Excessive
consumption of dietary sodium (or salt) has been
associated with adverse health outcomes [9, 10],
including hypertension, stroke, and coronary heart
disease [11, 12]. A sustained drop in salt intake of
about 4.0 g/day could result in a 4.2 mmHg reduc-
tion in blood pressure [15]. Hypertension is a known
risk factor for dementia for people in midlife to late
life [11]. While there is consensus on the need to
reduce sodium consumption for the prevention and
treatment of hypertension [12, 13], the evidence on an
association between sodium consumption, cognitive
impairment, and dementia risk remains limited.
Animal studies have demonstrated that high
dietary salt is associated with neurotoxicity
(increased amyloid aggregates) [14] and effects
systemic and cerebral blood vessels [15, 16], all of
which have been linked to cognitive impairment
and dementia. More recent findings in animal
studies have also suggested that the effect of salt on
cognition may occur via a gut-mediated pathway
[17]. A high sodium diet in mice leads to an adaptive
immune response in the gut which then reduces
blood flow to the brain, and promotes neurovascular
and cognitive impairment [17]. Therefore, salt
reduction may reduce dementia risk via its benefits
on cardio-metabolic health and inflammation, both
of which have been found to contribute to dementia
risk [18–20]. In humans, healthy dietary patterns
with low sodium levels, such as the Mediterranean
diet (MD) [21, 22] or the Dietary Approach to
Stop Hypertension (DASH) diet [23, 24], have been
associated with better cognitive function.
The aim of this systematic review was to summa-
rize the current evidence on the association between
dietary sodium intake, cognitive function and demen-
tia risk. The findings will be important for informing
the development of new intervention and prevention
strategies targeting cognitive function. Indeed, being
able to reduce the global burden of disease associ-
ated with impaired cognitive function and dementia
will have significant personal, social and economic
consequences.
METHODS
Protocol registration
This review was carried out according to the Pre-
ferred Reporting Items for Systematic Reviews and
Meta-analyses statement [25]. The review protocol
was registered on PROSPERO (CRD4201914632).
Search strategies and study selection
A systematic search for eligible publications was
performed in six electronic databases (Pubmed,
Embase, CINAHL, Psych info, Web of Science,
and Cochrane Library) from inception to 1 March
2020. The search terms were salt, sodium, natrium,
intake, consumption, feeding, old age, elderly, aged,
geriatric, people, adults, population, cognitive, mem-
ory, mental, impairment, function, decline, dementia,
Alzheimer. The detailed search strategy is described
in Supplementary Table 1. Titles and abstracts of the
identified studies were screened for inclusion by two
authors (KHY and YCS). Studies that were not rele-
vant were excluded. Full papers were sought for all
studies meeting the inclusion criteria and final selec-
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tions were made by two authors (DM and KHY).
Articles were included if they were 1) human stud-
ies of middle and older aged adults (aged 45 years
and above); 2) original research articles published
in peer reviewed scientific journals; and, 3) stud-
ies presenting data on cognition and sodium or salt
intake with the following study designs: prospec-
tive cohorts, cross-sectional studies, clinical trials
and case control studies. There were no restrictions
on baseline cognitive function. Only English articles
were considered. Studies were excluded if there was
insufficient information to allow for a critical eval-
uation of the strength and direction of the results.
Specifically, eligible studies had to include informa-
tion on measurement of dietary sodium or salt intake,
cognitive function, and/or dementia and report details
on the association between dietary sodium intake with
dementia risk and cognitive decline.
Data extraction and quality assessment
Data was extracted by one investigator (KHY)
using a standardized electronic template. Data entries
were then independently checked for completeness
and inconsistencies by a second investigator (DM).
Any discrepancies were resolved by consensus.
Extracted data included study design, country, study
population characteristics, sample size, sodium or salt
intake classification, details of dementia status and
cognitive function, methods of assessment of sodium
or salt intake, cognitive function or dementia risk,
and summary measures of the association between
salt or sodium intake with risk of dementia, cogni-
tive decline, or cognitive impairment. Further details
of potential confounders including age, sex, race,
education, body mass index (BMI), health-related
comorbidities, physical activity, alcohol intake, and
total energy intake were also recorded. In this paper,
we have considered the terms salt and sodium as
equivalent. However, when extracting the data, the
specific measurement of salt or sodium intake is
reported as in the original manuscript.
Risk of bias assessments were performed using the
National Heart, Lung, and Blood Institute (NHLBI)
assessment tool [26]. Studies were rated as “good”
(low risk of bias), “fair” (intermediate risk of bias),
or “poor” (high risk of bias). Quality was assessed by
one reviewer (KHY) and double checked by a sec-
ond reviewer (YCS). Disagreements were resolved
by consensus or by consulting a third reviewer (DM).
Synthesis of results
Due to heterogeneity in study design and large
differences in the assessment of salt/sodium intake
and cognitive function, it was not possible to pool
results in a meta-analysis. Therefore, we have pre-
sented the results stratified by cognitive domains
(including global cognition, memory, executive func-
tion, processing speed and other). The results for the
association between sodium or salt intake with mild
cognitive impairment (MCI) or dementia are also
reported separately.
RESULTS
Study selection
From the electronic search, 725 articles were iden-
tified; of which 156 were duplicates and therefore
removed. After title and abstract screening 542 papers
were excluded leaving 27 for full text review. From
the full text review, 15 studies fulfilled the inclusion
criteria and were included in the review (see Fig. 1).
Study characteristics
This review includes data from one clinical
trial [27], six longitudinal cohort studies [28–33]
(of which three studies only reported results of
cross-sectional analyses [30, 31, 33]) and eight cross-
sectional studies [34–41] (Table 1). Six of the studies
were conducted in the United States of America
(USA) [27–29, 31, 32, 39], two studies were con-
ducted in Australia [33, 36], and one study each was
conducted in Canada [30], Turkey [34], Korea [37],
Poland [35], Scotland [38], Ireland [40], and China
[41]. The only clinical trial included 160 participants
who had subjective memory complaints, objective
cognitive impairment (as assessed with the Mon-
treal Cognitive Assessment [MoCA]), and at least
one cardiovascular risk factor [27]. Mean age was
65.4 years (SD = 6.8) with a follow-up time of six
months. The six [28–33] cohort studies had sample
sizes ranging from 1,194 [29] to 6,426 [28] partic-
ipants. Age ranged from 40 to 96 (only one study
[32] included participants aged 40 years and above,
with the mean age of participants higher than 45 years
old). Follow-up time ranged from three to 36 years.
The remaining eight [34–41] cross-sectional studies
had sample sizes ranging from 44 [40] to 402 [35]
participants with ages ranging from 50 to 85 years.
Thirteen studies included both men and women, with
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Fig. 1. Flow diagram of study selection.
two studies only including post-menopausal women
[28, 35].
A total of 55 independent analyses examining the
association between sodium or salt intake and cog-
nitive outcomes were extracted from the 15 studies;
out of which 26 analyses adjusted the results for con-
founding factors.
Risk of bias/Quality assessment
Based on the NIHLB assessment tool four studies
were rated as “good” [27–30], five were classified
as “fair” [31–34, 37], and six studies were rated as
“poor” [35, 36, 38–41]. The main issues across the
studies included poorly defined study populations,
non-reporting of participating rate, large proportion
of missing data, and no adjustment for confounding
factors.
See Supplementary Tables 2 and 3 for the rating of
each study.
Assessment of sodium and salt intake
Sodium or salt intake was assessed using a wide
variety of methods and four studies used more than
one assessment of sodium intake [29–31, 34]. Seven
studies [27–31, 38, 40] assessed sodium or salt
intake with food frequency questionnaires (FFQs),
five studies [27, 35–37, 39] used food diaries, two
studies [28, 34] used 24-hour urinary sodium excre-
tion, two studies used single self-reported salt-intake
questions [32, 41], and one study used two self-
reported salt-intake questions [33]. Two studies [29,
37] used sodium/potassium intake ratios (Na/K) to
assess sodium intake.
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Table 1
Characteristics of reviewed studies
Study Country, Study population Sample How salt How cognitive function/status Cognitive
settings and size intake was was ascertained outcome
design estimated Assessed
Haring et al. [28] USA, clinical From WHIMS study cohort - a hormone 6426 WHI-FFQ for Yearly screening with 3MS, if score Cognitive decline
longitudinal replacement therapy trial of postmenopausal all participants below pre-established cut-off points,
cohort study women: and 24-h the following were used to determine
1. Sex distribution: all women urinary sodium cognitive status of normal, MCI or
2. Aged between 65 – 79 years excretion in a probable dementia (in accordance with
3. Mean follow-up period: 9.1 years. subsample of DSM-IV criteria):
4. Cognitive status at enrolment: dementia free women to 1. Consortium to Establish a Registry
5. Inclusion/exclusion: only hypertensive correct for the for Alzheimer’s Disease (CERAD)
women and normotensive but on anti- dietary self- battery,
hypertensive medications were included in report. 2. MMSE
the analysis. Women with incomplete data, 3. Trail Making Test parts A and B
or extreme caloric intake were excluded. 4. A structured psychiatric interview
(PRIMEMD)
5. 15-item Geriatric Depression
Scale-short form
6. Acquired cognitive and behavioral
changes interview completed by a
knowledgeable friend or family
member.
Nowak et al. [29] USA, From the Health ABC study cohort - healthy men 1194 FFQ (108 items) Yearly 3MS performed, Cognitive decline
community, and women from a sample of Medicare cognitive decline defined as
longitudinal beneficiaries score of ≥ 1.5 SD above the mean
cohort 1. Sex distribution: more women (55.6%) than
men (44.4%)
2. Aged between 70-79 years old with
3. Median follow up of 6.9 ± 0.1 years.
4. Cognitive status at enrolment: cognitively
intact, cognitive impairment at baseline
(3MS ≥ 1.5 SD above the mean)
5. Inclusion/exclusion: Participants with
missing data, implausible dietary data,
sodium intake < 500 mg/day or potassium
intake > 1000 mg/day were excluded.
(Continued)
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(Continued)
Study Country, Study population Sample How salt How cognitive function/status Cognitive
settings and size intake was was ascertained outcome
design estimated Assessed
Blumenthal et al. [27] USA, clinical, From the ENLIGHTEN clinical trial, inactive 160 FFQ+Four- Neuropsychiatric battery used to assess Cognitive improvement
clinical trial older men and women day food diary, cognitive function:
1. Sex distribution: men (34%) and women (66%) using DASH 1. Executive: Trail Making Test, Stroop
2. Mean age 65.4 (SD 6.8) scoring test, Digit span forward. Backward
3. Follow-up period: 6 months algorithm from subtest from Weschler Adult
4. Cognitive status at enrolment: dementia free Epstein and Intelligence Scale, Digit symbol
but with subjective memory complaints and Folsom substitution test from Weschler Adult
objective cognitive impairment Intelligence Test, Ruff 2 & 7 test and
5. Inclusion/exclusion: included if participant Animal Naming Test
had at least 1 CVD risk factor (together with 2. Memory: Hopkins Verbal learning
the qualifying cognitive status of subjective Test- revised, Medical College of
memory complaints and objective cognitive Georgia Complex Figure Test,
impairment), excluded if they had missing Language/verbal fluency: Controlled
data, were cognitively impaired (MCI) at Oral Word Association Test (COWA)
baseline, incomplete dietary information or and Animal Naming Test.
extreme caloric intake (<500 kcal or > 3500 3. Changes in global function was
kcal per day). assessed using modified CDR Sum of
6. Intervention - randomized into 2 x 2 factorial Boxes (a clinical interview)
interventions of: aerobic exercise alone,
DASH diet alone, aerobic exercise and But for sodium, only executive
DASH or health education alone function was mentioned – a composite
score of all the executive functioning
tests was derived.
Fiocco et al. [30] Canada, From the NuAge cohort of community dwelling 1262 78-item 3MS score of ≥ 79 was used to Cognitive function
community, men and women: semiquantitative define cognitive impairment.
cross 1. Sex distribution: men (49%) and women FFQ
sectional (51%)
analysis from 2. Aged between 67-84 years.
a longitudinal 3. Cognitive status at enrolment: dementia free
cohort - participants with baseline cognitive
impairment (defined as 3MS ≥ 79) were
excluded
4. Inclusion/exclusion: Individuals with missing
information or presence of neurological
diseases which can impact brain health
(cerebral vascular disease, Parkinson’s
disease, epilepsy or muscular dystrophy)
were excluded
D
.M
ohan
et
al./Sodium
Intake
a
nd
Cognitive
O
utcom
es
1353
Rush et al. [31] USA, Drawn from the Rancho Bernado cohort of 925 Willet FFQ Neuropsychological battery measuring Cognitive
community, community dwelling healthy men and women (153 items) 1 domain, and one screening test: function
cross 1. Sex distribution: men (40%) and women 1. Executive: Verbal Fluency Test and
sectional (60%) Trail Making test (B)
analysis from 2. Aged between 50 to 96 years old (mean age 2. Screening: MMSE
a longitudinal 74.5 ± 8.7) Definition of cognitive impairment:
cohort 3. Cognitive status at enrolment: No exclusions >132 for Trails B,<26 for MMSE and
were performed on the basis of baseline <12 for Verbal Fluency Test
cognitive status.
4. Inclusion/Exclusion: Participants with
missing data were excluded from analysis.
Afsar [34] Turkey, From an outpatient nephrology unit in a hospital 119 24-h urinary MMSE, scores used on a continuous Cognitive
clinical, cross- of newly diagnosed essential hypertension sodium excretion measure, no cut-offs imposed function
sectional 1. Sex distribution: men (42%) and women
Study (58%)
2. Mean age of 54.2 ± 16.1 years.
3. Cognitive status at baseline: No exclusions
were performed on the basis of baseline
cognitive status.
Hwang and Kim [37] Korea, clinical, From a cardiovascular outpatient clinic of heart 91 Three-day Seoul Neuropsychological Screening Cognitive function
cross-sectional study failure food diary Battery (SNSB) measuring 2 domains
1. Sex distribution: More male (70%) compared and one screening test:
to female (30%) patients 1. Screening: MMSE (Korean version)
2. Mean age of 57 ± 14.1 years and range age of 2. Memory: Seoul Verbal learning Test
21 to 79 years. (immediate and delayed recall memory)
3. Cognitive status at enrolment: intact 3. Executive: Controlled Oral Word
cognitive functioning as defined by exclusion Association test
criteria
4. Inclusion/exclusion: Participants were
excluded if they experienced acute cardiac
events within 3 months prior to enrolment,
visual or hearing impairment and
documented pathologic conditions that
compromised cognitive functioning (such as
dementia, stroke, psychiatric condition or
renal failure requiring dialysis).
(Continued)
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(Continued)
Study Country, Study population Sample How salt How cognitive function/status Cognitive
settings and size intake was was ascertained outcome
design estimated Assessed
Brownbill and Ilich [39] USA, From another longitudinal study of community 97 Three-day MMSE – normal cognition was Cognitive
community, dwelling healthy post-menopausal women food diary defined as MMSE ≥ 27, impaired function
cross- investigating association of reduced sodium cognition defined as MMSE < 27
sectional study intake on bone health.
1. Sex distribution: all post-menopausal women
2. Mean age of 69.7 (±6.7).
3. Cognitive status at baseline: cognitively well
– no exclusions were performed on the basis
of baseline cognitive status. Participants had
average MMSE of 27.9 (range 22-30)
4. Inclusion/exclusion: no others mentioned
Li et al. [32] USA, From the Framingham Offspring cohort of 2461 Self-reported Participants would undergo MMSE and Cognitive
community, community dwelling healthy men and women question: Low neuropsychological assessments at decline
longitudinal 1. Sex distribution: men (49.5%) and women salt diet study visits and dementia was
cohort (50.5%) diagnosed according to DSM-IV |
2. Aged between 40 to 65 years old at baseline criteria (for Alzheimer’s Disease type
3. Follow up of more than 30 years. dementia) or according to the National
4. Cognitive status at enrolment: not demented at baseline Institute of Neurological Disorders and
5. Inclusion/exclusion: Men and women Stroke and the Association
diagnosed with dementia at baseline were Internationale pour la Recherche et
excluded from the study. l’Enseignement en Neurosciences
(NINDS–AIREN) (for vascular type
dementia).
Koh et al. [36] Australia, From an independent living facility: Illawarra 47 Three-day Measured 3 cognitive domains: Cognitive
independent Retirement Trust. food diary 1. Executive: Verbal Fluency Test, function
living facility, 1. Sex distribution: men (36%) and women Trail Making Test, Digit Span
cross- (64%) Backwards
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sectional 2. Mean age of 78.2 ± 6.1 years 3. 3. Cognitive 2. Memory: Rey Auditory Verba
study status at enrolment: Participants were l Learning Test (RAVLT)
described as having no serious cognitive 3. Language: Boston Naming test
impairment at inclusion.
3. Inclusion/exclusion: participants with
incomplete data were excluded.
Bojar et al. [35] Poland, From community dwelling healthy post- 402 Seven-day Used a neuropsychological battery (the Cognitive
community, menopausal women food diary CNS Vital Signs) to determine function
cross- 1. Sex distribution: all women cognitive function- seven cognitive
sectional 2. Aged between 50-65 years. domains:
study 3. Cognitive status at enrolment: cognitively 1. Memory: verbal and Visual memory
normal (MoCA > 26) test
4. Inclusion/exclusion: Participants were 2. Processing speed: Symbol Digit test
excluded if they had active cancerous disease 3. Executive: Shifting Attention Test
within 5 years before enrolment into study, 4. Psychomotor speed: Finger Tapping
mental diseases (depression, substance and Symbol Digits test
addiction or diagnosed nosologic unit with 5. Reaction time: Stroop test
symptoms of dementia. 6. Attention: Continuous performance
test, Shifting Attention Test, Stroop test
7. Cognitive flexibility: Shifting
attention test
Results were broken down by domains
Salerno- Ireland, Community dwelling healthy adults: including 44 Semi- MMSE - normal MMSE>24, impaired Cognitive
Kennedy and community, first degree blood relatives of AD patients. quantitative defined as MMSE=24 function
Cashman [40] cross- 1. Sex distribution: More women (72.7%) FFQ
sectional compared to men (37.3%).
study 2. Mean age of participants 57.7 (SD 9.4)
3. Cognitive status at enrolment: No exclusions
were performed on the basis of baseline
cognitive status.
4. Inclusion/exclusion: Subjects were excluded
from the study if they suffered from
depression and stroke.
(Continued)
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(Continued)
Study Country, Study population Sample How salt How cognitive function/status Cognitive
settings and size intake was was ascertained outcome
design estimated assessed
del C. Valde´s Scotland, From the Lothian Birth Cohort 1936 – community 189 Scottish Neuropsychological battery generating Cognitive
Herna´ndez community, dwelling healthy men and women Collaborative three domains, composite scoring with function
et al. [38] cross- 1. Sex distribution: more women (54%) Group Food PCA:
sectional compared to men (46%) Frequency 1. General cognitive factor- Digit
study 2. Mean age of 72.7 (SD 0.8). Questionnaire Symbol, Digit Span Backward, Symbol
3. Cognitive status at enrolment: no dementia Search, Letter-Number Sequencing,
4. Inclusion/exclusion: Analysis only included Block Design and Matrix Reasoning
the extreme /middle /avoidance of iodine 2. Memory - Logical memory Total
intake subgroups of participants Immediate and Delayed recall, Verbal
Paired Associates Immediate and
Delayed Recall, Spatial Apn Total
Score, Letter-Number Sequencing and
Digit Span Backward
3. Speed - Simple Reaction Time and
Choice Reaction Time
Milte et al. Australia, From the Wellbeing, Eating and Exercise for a 617 Self-reported Telephone Interview for Cognitive Cognitive
[33] community, Long Life (WELL) study. questions on Status Modified (TICS-m). Scores can function
cross 1. Sex distribution: nearly equal proportions of whether: range from 0 to 50. Cut offs for
sectional men (49%) and women (51%) 1. “Salt added cognitive categories were:
analysis from 2. Aged between 55 to 65 years old. to your food 1. Normal cognitive function - score
a population 3. Cognitive status at enrolment: No exclusions during of 32 and above
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based were performed on the basis of baseline cooking” 2. Possible mild cognitive
longitudinal cognitive status. (response impairment - score of between 31
cohort study 4. Inclusion/exclusion: Only participants with choices and 28
complete data were included in the analyses. "Never", 3. Possible dementia - score of 27
Responses for salt intake were collected in “Sometimes”, and below.
2010 and 2014. Cognitive function tests were “Usually”,
conducted in 2014 by telephone interview. “Don’t
Know”) and
2. “Salt added
to your food
after it is
cooked”
(response
choices of
“Never”,
“Sometimes”
and “Usually”)
Yao et al. [41] China, All community-dwelling older adults from two 2809 Self-reported Chinese version of the MMSE (C- Cognitive
community, towns in a Shanghai sub-district: question: MMSE) used. Cut-offs for cognitive function
cross- 1. Sex distribution: more women (64%) Preferring impairment were according to
sectional participants than men (36%). non-salty diet education level:
study 2. Aged 60 years and above (yes/no) Without formal education - score 17
3. Cognitive status at baseline: no dementia and below
4. Inclusion/exclusion: Participants were With 1 to 6 years education - score of
excluded if they were hearing impaired, 20 and below
speech impaired, diagnosed with dementia, With more than 6 years of education -
refused to cooperate or in psychosis. score of 24 and below
3MS, The Modified Mini-Mental State Test; AD, Alzheimer’s disease; DASH, Dietary Approaches to Stop Hypertension diet; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders
(fourth edition); FFQ, Food frequency questionnaire; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; PCA, Principal Component Analysis; SD, standard
deviation
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Assessment of cognitive function, MCI, and
dementia
There were large differences in how cognitive
function was assessed. The most frequently used
tests included the Mini-Mental State Examination
(MMSE) (six studies [31, 33, 34, 37, 39, 40]),
modified Mini-Mental State Examination (3MS, two
studies [29, 30]), Verbal Fluency Test (two studies
[31, 36]), and the Trail Making Test (two studies [27,
36]). Only one study used the Telephone Interview
for Cognitive Status Modified (TICS-m) [41]. Three
studies combined cognitive measurements to derive
composite scores of cognitive performance [27, 35,
38]. Seven studies used more than one measure of
cognition [27, 28, 31, 35–38].
Two studies [28, 32] assessed clinical status,
including MCI or dementia (all-cause). Dementia
was diagnosed using the criteria from the Diagnostic
and Statistical Manual of Mental Disorders Fourth
Edition (DSM-IV). MCI was diagnosed if the par-
ticipant scored in the 10th or lower percentile in at
least one area of cognitive function on modified neu-
ropsychological tests established by the Consortium
to Establish a Registry for Alzheimer’s Disease or if
the participant was reported to suffer from some func-
tional impairment but still performed well in basic
activities of daily living as reported by a reliable infor-
mant [28]. A study by Li et al. [32] additionally used
the criteria from National Institute of Neurological
Disorders and Stroke and the Association Inter-
nationale pour la Recherche et l’Enseignementen
Neurosciences (NINDS–AIREN) for the diagnosis
of vascular dementia.
Global cognition
Eight studies [29–31, 33, 34, 37, 39–41], with sam-
ple sizes ranging from 44 [35] to 1,262 [30], reported
associations between sodium intake and global cog-
nitive function measured using single tests including
the MMSE, 3MS, or the TICS-m (see Table 2). Only
one study was analyzed prospectively [29], the others
were cross-sectional [31, 33, 34, 37, 39–41]. Overall,
the results were mixed. In studies using the MMSE
or 3MS, four [29, 30, 34, 40] showed that higher
dietary sodium was associated with poor global cog-
nitive function, one study showed that lower dietary
sodium preference was associated with better cogni-
tive function [41], and one study showed that higher
sodium was associated with better MMSE scores
[31]. The remaining two studies reported no asso-
ciations [37, 39].
The only study utilizing the TICS-m reported no
association in the total study sample and mixed asso-
ciations when the analyses were stratified by sex [33].
Men who reported they “usually” add salt during
cooking had poorer cognitive function than men who
reported “never”. In contrast, women who reported
they “sometimes” add salt after cooking had better
cognitive function than women who reported “never”.
Two studies [35, 38] using a composite of tests to
derive a global cognition score both reported no asso-
ciation between sodium intake and cognitive function
(see Table 2).
Four studies [27–30] were rated as “good” quality,
five studies [31–34, 37] were rated as “fair”, and six
studies [35, 36, 38–41] were rated as “poor”. When
restricting the analysis to high quality studies only
(n = 2 studies [29, 30]) the results were consistent;
Nowak et al. [29] showed that a higher Na/K ratio was
associated with cognitive decline (OR = 2.02, 95%
CI: 1.01–4.03) and Fiocco et al. [30] showed that
higher sodium intake was associated with cognitive
decline in older subjects with low physical activity.
Memory
Four cross-sectional studies, with sample sizes
ranging from 44 to 189, reported associations
between sodium intake and memory [35–38] (see
Table 3). Eleven different memory tests were used
and two studies [35, 38] created composite scores
including more than one test. One study [37] was
rated as “fair” while the remaining three studies [35,
36, 38] were rated as “poor” quality. The only statis-
tically significant association between sodium intake
and memory function was found in the study con-
ducted by Hwang and Kim [37]. This study analyzed
the relationship between Na/K quartiles with mem-
ory function in heart failure patients and observed that
the lowest and highest quartiles of Na/K ratio were
associated with poorer memory scores compared to
the second and third quartiles of Na/K ratio.
Executive function
Five studies [27, 31, 35–37] with sample sizes
ranging from 44 to 925 reported associations between
sodium intake and executive function (see Table 4).
Twelve types of tests were used to assess execu-
tive function with the Trail Making Test the most
commonly used (n = 3 studies [27, 31, 36]). Only
two studies reported significant associations between
sodium and executive function, but the results were
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Table 2
The association between sodium intake and global cognition (measured by screening tools)
Studies Quality Salt Type of Categorization Type of Results Direction of
assessment categorization cognitive of cognitive analysis association
assessment scores/function
Nowak et al. Good Sodium 3MS Categorical, Logistic For sodium No
[29] measured in 3MS score regression Sodium quartiles OR (95% CI) association
mg/day, (≥1.5 SD of Q1 597-1921 mg/day Ref
divided into mean decline) Q2 1921-2511 mg/day 0.82 (0.45-1.47)
quartiles, = CI Q3 2511-3264 mg/day 0.65 (0.34-1.27)
Q4 3264-11565 mg/day 0.94 (0.42-2.10)
Adjusted for: Age, sex, race, education, smoking, BMI, SBP, hypertension
history, stroke, CVD, diabetes, estimated glomerular filtration rate, total kcals
Sodium 3MS Categorical, Logistic For sodium OR (95% CI) No
measured in 3MS score regression Continuous 0.96 (0.50-1.84) association
mg/day, (≥1.5 SD of (log2 transformed)
continuous mean decline) Adjusted for: Age, sex, race, education, smoking, BMI, SBP, hypertension
measures = CI history, stroke, CVD, diabetes, estimated glomerular filtration rate, total kcals
Sodium/potassium 3MS Categorical, Logistic For sodium/potassium ratio No
ratio was 3MS score regression Na/K quartiles OR (95% CI) association
calculated, (≥1.5 SD of Q1 0.350-0.743 Ref
divided into mean decline) Q2 0.743-0.904 1.16 (0.64-1.55)
quartiles, = CI Q3 0.904-1.083 0.84 (0.45-1.55)
Q4 1.083-2.400 1.36 (0.77-2.38)
Adjusted for: Age, sex, race, education, smoking, BMI, SBP, hypertension
history, stroke, CVD, diabetes, estimated glomerular filtration rate, total kcals
Sodium/potassium 3MS Categorical, Logistic For sodium/potassium OR (95% CI) Higher
ratio was 3MS score regression Continuous 2.02 (1.01-4.03) sodium:
calculated in (≥1.5 SD of potassium –>
continuous mean decline) Adjusted for: Age, sex, race, education, smoking, BMI, SBP, hypertension CI
measures = CI history, stroke, CVD, diabetes, estimated glomerular filtration rate, total kcals
Fiocco et al. Good Sodium 3MS Categorical, CI GEE Outcome: Baseline cognitive function No
[30] measured in defined as <79 Sodium intake tertile Median 3MS (SD) p association
mg/day, split Low (median: 1800) 93.74 (0.002) 0.21
into tertiles Medium (median: 2634) 94.05 (0.003)
High (median: 3701) 93.44 (0.003)
Sodium 3MS Categorical, CI GEE Outcome: Baseline cognitive function No
measured in defined as < 79 Sodium intake tertile Median 3MS (SD) association
mg/day, split Low activity High activity
into tertiles Low (median: 1800) 94.14 (0.16) 93.45 (0.17)
Medium (median: 2634) 93.91 (0.15) 94.25 (0.17)
High (median: 3701) 93.42 (0.16) 93.50 (0.17)
p 0.82 0.76
Adjusted for: Age, sex, education, diabetes, waist circumference, energy,
cholesterol, calcium and Canadian Healthy Eating Index total score
(Continued)
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(Continued)
Studies Quality Salt Type of Categorization Type of Results Direction of
assessment categorization cognitive of cognitive analysis association
assessment scores/function
Sodium 3MS Categorical, CI GEE Outcome: Change in cog function over years No
measured in defined as <79 Sodium intake tertile Median (SD) p association
mg/day, split Low (median: 1800) –1.18 (0.03) 0.11
into tertiles Medium (median: 2634) -1.83 (0.003)
High (median: 3701) –1.53 (0.004)
Sodium 3MS Categorical, CI GEE Stratified by baseline physical activity level - only in low physical activity Higher
measured in defined as <79 group there was association sodium
mg/day, split Outcome: Change in cog function over years → more
into tertiles Sodium intake tertile M (SD) p cognitive
Low (median: 1800) -0.86 (0.003) 0.0005 decline
Medium (median: 2634) –2.31 (0.01)
High (median: 3701) –2.24 (0.01) in low
Adjusted for: Age, sex, education, diabetes, waist circumference, energy, physical
cholesterol, calcium and Canadian Healthy Eating Index total score activity group
Rush et al. Fair Sodium MMSE Continuous Linear Dependent variable: MMSE score For MMSE in
[31] measured in regression continuous
mg/day, in β = 0.09, p = 0.007 measures
continuous Adjusted for: Age, sex, education, total caloric intake, daily potassium intake, lower sodium
measures calcium intake, Mediterranean diet score –> CI
Sodium MMSE Categorical, Logistic Outcome: CI For MMSE in
measured in CI= MMSE < regression OR (95% CI) categorical
mg/day, cut- 26 Sodium =1.15 (1.02-1.28) measures
off at normal=MMSE Adjusted for: Age, sex, education, total caloric intake, daily potassium intake, lower sodium
MMSE=26 ≥ 26 calcium intake, Mediterranean diet score –> CI
Sodium MMSE Continuous Linear test Mean test scores by caloric adjusted sodium intake quartiles Higher
measured in for trend p = 0.007 sodium ->
mg/day, in Adjusted for: Age, sex, education level, total caloric intake better
quartiles cognition
Afsar [34] Fair Sodium MMSE Continuous Linear Outcome: log transformed 24-h Na excretion Higher
measured in regression MMSE: B = −0.0033, 95%CI = –0.049, –0.017, p < 0.0001 sodium –> CI
mEq/day, log Adjusted for: Gender, creatinine clearance, SBP
transformed
Sodium MMSE Continuous Spearman’s r = −0.300, p = 0.001 Higher
measured in correlation sodium –> CI
mEq/day, log
transformed
Hwang and Fair Sodium/potas MMSE Continuous ANOVA Na/K quartile F p No
Kim [37] sium ratio, Q1 (M ± SD) 25.52 ± 5.93 2.20 0.09 association
split into Q2 (M ± SD) 27.09 ± 3.27
quartiles Q3 (M ± SD) 28.52 ± 2.06
Q4 (M ± SD) 26.04 ± 4.35
D
.M
ohan
et
al./Sodium
Intake
a
nd
Cognitive
O
utcom
es
1361
Salerno- Poor Sodium MMSE Categorical Kruskal Sodium levels, Mean ± SD p Higher
Kennedy measured in CI = MMSE ≤24 Wallis/ MMSE>24 (n = 40), Na 1.9 ± 0.9 0.037 sodium → CI
and mg/day, in Normal=MMSE Mann MMSE=<24 (n = 4), Na 3.9 ± -2.1
Cashman continuous >24 Whitney
[40] measures
del C. Poor Sodium Digit Continuous Linear β = −0.05, p = 0.56 No
Valde´s measured in Symbol, regression association
Herna´ndez mg/day, in Digit Span
et al. [38] continuous Backward,
measures Symbol
Search,
Letter-
Number
Sequencing,
Block
Design and
Matrix
Reasoning
Bojar et al. Poor Sodium Composite Continuous Pearson’s Cognition measure r p No
[35] measured in of 5 correlation composite domains 0.086 0.085 association
mg/day, in domains:
continuous memory,
measures psychomotor
speed,
reaction
time,
complex
attention,
cognitive
flexibility
Brownbill Poor Sodium MMSE Categorical: ANOVA Sodium levels, Mean ± SD No
and Ilich measured in normal = 27-30 MCI group (n=34), 2114 ± 661 association
[39] mg/day, mild CI = lower Normal group (n=63), 2322 ± 955
continuous than 27
Yao et al. Poor Categorical, C-MMSE Categorical, Logistic Outcome: CI Lower sodium
[41] self-reported according to regression Preferring non-salty diet OR (95% CI) → better
question: education level No reference cognitive
Preferring 1. No education: Yes 0.647 (0.46 - 0.91) function
non-salty diet Normal= 18 Adjusted for: Age
(yes/no) above
CI = 17 below
2. 1-6 years:
Normal = 21
above
CI = 20 below
(Continued)
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(Continued)
Studies Quality Salt Type of Categorization Type of Results Direction of
assessment categorization cognitive of cognitive analysis association
assessment scores/function
3. >6 years:
Normal=25
above
CI=24 below
Milte et al. Fair Categorical, TICS-m Categorical: Multiple Outcome: MCI or dementia
[33] two questions Normal = 32 linear
on addition of and above regression
salt to food: CI= below 32 For salt added during cooking (in 2010) - B(95%CI) for total and stratified by No
1. “Salt added sex association
to your food Response Total Men Women
during Never reference reference reference
cooking” Sometimes 0.07 (-0.59, 0.73) -0.27 (-1.29, 0.76) 0.41 (-0.58, 1.40)
(Never/Someti Usually 0.11 (-0.79, 1.00) -0.32 (-1.83, 1.18) 0.54 (-0.33, 1.41)
mes/Usually/ For salt added during cooking (in 2014) - B(95%CI) for total and stratified by
Don’t Know) sex Usually add
2. “Salt added Response Total Men Women salt during
to your food Never reference reference reference cooking ->
after it is Sometimes -0.49 (-1.14, 0.16) -0.65 (-1.48, 0.18) -0.13 (-1.26, 0.99) poorer
cooked” Usually -1.12 (-2.04, -0.19) -1.37 (-2.39, -0.35) -0.47 (-1.70, 0.76) cognitive
(Never/Someti Don’t know -0.93 (-2.98, 1.13) -0.91 (-3.04, 1.21) n/a function (in
mes/Usually) men only)
For salt added after cooking (in 2010) - B(95%CI) for total and stratified by Sometimes
sex add salt after
Response Total Men Women cooking ->
Never reference reference reference better
Sometimes 0.34 (-0.23, 0.91) 0.05 (-0.99, 1.08) 0.98 (0.25, 1.71) cognitive
Usually 0.23 (-0.72, 1.19) -0.18 (-1.58, 1.23) 0.63 (-0.23, 1.49) function (in
women only)
For salt added after cooking (in 2014) - B(95%CI) for total and stratified by No
sex association
Response Total Men Women
Never reference reference reference
Sometimes 0.07 (-0.59, 0.73) -0.27 (-1.29, 0.76) 0.41 (-0.58, 1.40)
Usually 0.11 (-0.79, 1.00) -0.32 (-1.83, 1.18) 0.54 (-0.33, 1.41)
All analyses adjusted for: Age, sex, education, urban/rural, clustering by
postcode, total physical activities
3MS, The Modified Mini-Mental State Test; ANOVA, Analysis of Variance; BMI, body mass index; CI, cognitive impairment; CVD, cardiovascular disease; GEE, generalized estimating equation;
MCI, mild cognitive impairment; MMSE, Mini-Mental State Examination; Na, sodium; Na/K, sodium/potassium ratio; r, correlation coefficient; SBP, systolic blood pressure; SD, standard
deviation; OR, odds ratio. C-MMSE = Chinese MMSE; TICS = Telephone Interview for Cognitive Status modified.
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Table 3
Association between sodium intake and memory
Studies Quality Salt categorization Type of cognitive Categorization Type of Results Direction of
assess- assessment of cognitive analysis association
ment scores
Bojar et al. Poor Sodium measured Verbal memory test Continuous Pearson’s Cognition measure r p No association
[35] in mg/day, in correlation Verbal Memory –0.037 0.456
continuous measures
Sodium measured Verbal memory test Continuous Pearson’s Cognition measure r p No association
in mg/day, in correlation Verbal Memory 0.071 0.158
continuous measures
Sodium measured Composite Verbal + Continuous Pearson’s Cognition measure r p No association
in mg/day, in Visual memory correlation Composite 0.016 0.085
continuous measures (Verbal + Visual memory)
Koh et al. Poor Sodium measured Rey’s Auditory Verbal Continuous Spearman’s Cognition measure r p No association
[36] in mg/day, in Learning test correlation RAVLT 0.055 >0.05 (not No association
continuous measures (RAVLT) shown exact)
Hwang and Fair Sodium/potassium ratio, Seoul verbal learning Continuous ANOVA Na/K quartile F p Higher Na/K–>better cognition,
Kim [37] split into quartiles test Immediate recall until a threshold, cognition scores
(Immediate recall Q1 (M ± SD) 12.91 ± 5.32 3.69 0.015, Q1<Q3 dip again, j-shaped
section) Q2 (M ± SD) 16.57 ± 5.01
Q3 (M ± SD) 18.43 ± 6.21
Q4 (M ± SD) 15.98 ± 5.98
Sodium/potassium ratio, Seoul verbal learning Continuous ANOVA Na/K quartile F p No association
split into quartiles test Delayed recall
(Delayed recall Q1 (M ± SD) 4.17 ± 1.95 1.93 0.13
section) Q2 (M ± SD) 4.87 ± 2.60
Q3 (M ± SD) 5.78 ± 2.00
Q4 (M ± SD) 4.98 ± 2.32
del C. Valde´s Sodium measured Composite score of: Continuous Linear = 0.09, p = 0.29 No association
Herna´ndez in mg/day, in Logical memory regression
et al. [38] continuous measures Total Immediate and
Delayed recall
Verbal Paired
Associates Immediate
and Delayed Recall
Spatial Span Total
Score Letter-Number
Sequencing
Digit Span Backward
ANOVA, Analysis of Variance; FFQ, Food frequency questionnaire; M, mean; Na/K, sodium/potassium ratio; r, correlation coefficient; SD, standard deviation.
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Association between sodium intake and executive function
Studies Quality Salt Type of Categorization Type of Results Direction of
assessment categorization cognitive of cognitive analysis association
assessment scores/function
Bojar et al. [35] Poor Sodium measured Shifting attention Continuous Pearson’s Cognition measure r p No association
in mg/day, in tests correlation Shifting Attention tests 092 0.065
continuous measures
Koh et al. [36] Poor Sodium measured Verbal fluency test Continuous Spearman’s Cognition measure r p No association
in mg/day, in (Letter Fluency) correlation Letter Fluency –0.141 >0.05
continuous measures
Sodium measured Verbal fluency test Continuous Spearman’s Cognition measure r p No association
in mg/day, in (Categorical Fluency) correlation Categorical Fluency –0.055 >0.05
continuous measures
Sodium measured Trail Making test Continuous Spearman’s Cognition measure r p No association
in mg/day, in (Categorical Fluency) correlation Trailmaking –0.111 >0.05
continuous measures
Sodium measured Digitspan backwards Continuous Spearman’s Cognition measure r p No association
in mg/day, in (Categorical Fluency) correlation Digitspan backwards –0.016 >0.05
continuous measures
Hwang and Kim Fair Sodium/potassium Controlled Oral Continuous ANOVA Na/K quartile F p No association
[37] ratio, split into Word Association Q1 (M ± SD) 17.22 ± 9.04 1.98 0.12
quartiles test Q2 (M ± SD) 21.43 ± 9.19
Q3 (M ± SD) 24.78 ± 11.65
Q4 (M ± SD) 21.18 ± 11.72
j-shaped but not statistically significant
Blumenthal Good Sodium measured Composite score of: Continuous GLM Dependent variable: composite score of cognitive tests Lower sodium –
et al. [27] in mg/day, in Trail Making Test, > better
continuous measures Stroop test, For sodium cognition
Digit span forward, b = 0.18, p = 0.024
Backward subtest
from Weschler Adult
Intelligence Scale,
Digit symbol
substitution test from
Weschler adult
Intelligence Test,
Ruff 2 & 7 test and
Animal Naming Test
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Rush et al. [31] Fair Sodium measured Verbal Fluency Test Continuous Linear Dependent variable: Verbal Fluency Test score No association
in mg/day, in regression For sodium: β = 0.006, p = 0.823
continuous measures Adjusted for: Age, sex, education, total caloric intake, daily
potassium intake, calcium intake, Mediterranean diet score
Sodium measured Verbal Fluency Test Continuous Linear test Mean test scores by caloric adjusted sodium intake quartiles Null
in mg/day, in for trend p = 0.897
in quartiles Adjusted for: Age, sex, education level, total caloric intake
*more like a inverted j-shaped relationship
Sodium measured Trailmaking Test Continuous Linear Dependent variable: Trailmaking Test scores Higher sodium -
in mg/day, in (Trail B) regression For sodium β = −0.079, p = 0.005 >better cognition
continuous measures Adjusted for: Age, sex, education, total caloric intake, daily
potassium intake, calcium intake, Mediterranean diet score
Sodium measured Trailmaking Test Continuous Linear Dependent variable: Trailmaking Test scores Higher sodium -
in mg/day, in (Trail B) regression sodium intake predicting for Trails B score stratified by age >better cognition
continuous measures <80 years old: standardized β = −0.04, p = 0.365
≥80 years old: standardized β = −0.15, p = 0.014
Adjusted for: Sex, education, total caloric intake
Sodium measured Trailmaking Test Continuous Linear test Mean test scores by caloric adjusted sodium intake quartiles Null
in mg/day, in (Trail B) for trend p = 0.073
in quartiles Adjusted for: Age, sex, education level, total caloric intake
ANOVA, Analysis of Variance; CVD, cardiovascular diseases; FFQ, Food frequency questionnaire; GLM, generalized linear model; M, mean; MoCA, Montreal Cognitive Assessment; Na/K,
sodium/potassium ratio; r, correlation coefficient; SD, standard deviation.
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mixed [27, 31]. The clinical trial, which had a low
risk of bias, reported that a lower sodium intake was
associated with improved executive function mea-
sured using a neuropsychological battery including
the Trail Making Test [27]. In contrast, the cross-
sectional study by Rush et al. [31], which was rated
as fair, reported that higher sodium intake was asso-
ciated with better performance on the Trail Making
Test. The remaining three cross-sectional studies
reported no association [35–37].
Processing speed
Only two cross-sectional studies [35, 38], with
sample sizes ranging from 189 to 402, examined asso-
ciations between sodium intake and processing speed
using different cognitive assessments. No significant
association was reported in either study (see Table 5).
Both studies were rated as “poor” quality.
Dementia and MCI
Only two prospective studies [28, 32] reported
associations between sodium intake with risk of
MCI or dementia (see Table 6). The follow-up
period for each study was a median of 9.1 years
[28] and 36 years [32]. The first study with low
bias of risk [28] stratified participants (n = 6426)
by different levels of sodium intake (FFQ sodium
level adjusted for 24 h urinary levels).They con-
cluded that for women in the sodium intakes tratum
of 2,300 mg to 3000 mg per day, hypertension was
associated with greater risk of probable demen-
tia/MCI in (HR = 1.28, 95%CI: 1.08–1.51) compared
to non-hypertension. The study also concluded that
for women in this stratum of sodium intake, those
on antihypertensive medication were at a higher
risk of probable dementia or MCI compared to
those not on antihypertensive medication (HR = 1.25,
95%CI:1.06–1.48).These associations were not sig-
nificant in other two strata of sodium intake (less
than 2300 mg/day and more than 3000 mg/day). For-
mal tests of interaction were also not significant. The
second study [32] found no significant association
between sodium intake and risk of incident dementia
(OR = 1.64, 95%CI: 0.95–2.83; n = 2461).
Other cognitive domains
Additional cognitive domains were tested in three
cross-sectional studies included “general” [38], “neu-
rocognition index” [35],“attention” [35], “cognitive
flexibility” [35], “psychomotor speed” [35], “reaction
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Table 6
Association between sodium intake and diagnosis of dementia or MCI
Studies Quality Salt Type of Categorization Type of Results Direction of
assessment categorization cognitive of cognitive analysis association
assessment scores/function (according to article)
Li et al. [32] Fair One question on Formal dementia Binary Logistic Demented Non-Demented Total % Dem None
“low salt diet”, diagnosis in regression All 227 2235 2462 9.2 Lower sodium–
binary “yes” health facilities Non-Low Salt 211 2136 2347 9.0 >dementia
“no” response Low salt diet 16 99 115 14.0 but not statistically
Logistic regression predicting for dementia significant
OR (95% CI) of Low Salt diet = 1.64 (0.95–2.83)
Haring et al. Good Sodium DSM-IV criteria Binary Hazards ratio Risk in hypertensive women only, before 24-h urine Mid range sodium in
[28] measured in for MCI/Probable adjustment HPT women –>CI
mg/day, Dementia Outcome MCI/ProbDem HR (95% CI)
analysis split sodium ≤1500 mg/day 1.23 (0.85-1.78)
into in groups of sodium 1501–2999 mg/day 1.24 (1.02-1.52)
sodium sodium >3000 mg/day 1.19 (0.90-1.57) Null
1. ≤1500
mg/day
2. 1501-2999 Risk in women on antihypertensive medication before
mg/day 24-hurine adjustment
3. >3000 Outcome MCI/ProbDem HR (95% CI)
mg/day sodium ≤1500 mg/day 1.18 (0.81-1.71)
sodium 1501-2999 mg/day 1.19 (0.97-1.46)
sodium >3000 mg/day 1.24 (0.94-1.64)
Adjusted for: Age, race, education, WHIM therapy arm,
baseline 3MS, alcohol, smoking, physical activity, diabetes,
BMI, depression, energy intake, CVD history
Sodium DSM-IV criteria Binary Hazards ratio Risk in hypertensive women only, before 24-h urine Mid range sodium in
measured in for MCI/Probable adjustment HPT women –>CI
mg/day, Dementia Outcome MCI/ProbDem HR (95% CI)
analysis split sodium ≤1500 mg/day 1.30 (0.91-1.87)
into in groups of sodium 1501–2999 mg/day 1.29 (1.06-1.57)
sodium sodium >3000 mg/day 1.29 (0.98-1.69)
1. ≤1500
mg/day
2. 1501-2999 Risk in women on antihypertensive medication before Mid and high range
mg/day 24-hurine adjustment sodium in HPT meds
3. >3000 Outcome MCI/ProbDem HR (95% CI) women –>CI
mg/day sodium ≤1500 mg/day 1.25 (0.86-1.80)
sodium 1501-2999 mg/day 1.25 (1.02-1.52)
sodium >3000 mg/day 1.36 (1.03-1.78)
Adjusted for: Age, race, education, baseline 3MS and WHI
menopausal hormone therapy arm
(Continued)
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(Continued)
Studies Quality Salt Type of Categorization Type of Results Direction of
assessment categorization cognitive of cognitive analysis association
assessment scores/function (according to article)
Sodium DSM-IV criteria Binary Hazards ratio Risk of MCI/Prob Dem in hypertensive women only, Mid range sodium in
measured in for MCI/Probable stratified by sodium levels (after 24-h urine adjustment) HPT women –>CI
mg/day, Dementia Outcome MCI/ProbDem HR (95% CI)
analysis split sodium <2300mg/day 1.56 (0.97-2.52)
into in groups of sodium 2300-3000mg/day 1.28 (1.08-1.51)
sodium sodium >3000 mg/day 1.32 (0.86-2.05)
after correction:
1. <2300 Risk in women on antihypertensive medication, after 24-h
mg/day urine adjustment Mid range sodium in
2. 2300-3000 Outcome MCI/ProbDem HPT meds women –
mg/day sodium <2300mg/day 1.53 (0.93-2.50) >CI
3. >3000 sodium 2300-3000mg/day 1.25 (1.06-1.48)
sodium >3000 mg/day 1.43 (0.93-2.21)
Adjusted for: Age, race, education, baseline 3MS and WHI
menopausal hormone therapy arm
3MS, The Modified Mini-Mental State Test; CI, cognitive impairment; CVD, cardiovascular; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders (fourth edition); HPT, hypertension;
HR, hazards ratio; OR, odds ratio; MCI, mild cognitive impairment; Prob Dem, probable dementia; WHI, Women’s Health Initiative (study).
Table 7
Association between sodium intake and other cognitive domains
Author Quality Salt Cognitive Type of cognitive Categorization Type of Results Direction of
assessment categorization domain assessment of cognitive analysis association
assessed scores/function
Bojar et al. Poor Sodium Attention Performance Test, Continuous Pearson’s Cognition measure r p No association
[35] measured in Shifting Attention correlation composite tests 0.078 0.119
mg/day, in Test, Stroop Test
continuous Cognitive Shifting Attention tests Cognition measure r p No association
measures flexibility Shifting Attention tests 0.095 0.058
Psychomotor Finger Tapping test Cognition measure r p No association
speed and Symbol digits composite tests –0.013 0.797
Reaction Stroop test Cognition measure r p No association
time Stroop tests 0.052 0.300
Koh et al. Poor Sodium Language Boston Naming Test Continuous Spearman’s Cognition measure r p No association
[36] measured in correlation Boston Naming test –0.153 >0.05
mg/day, in
continuous
measures
r, correlation coefficient.
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time” [35], and “language” [36] (Table 7). Overall,
studies had a small sample size (ranging from 47
[36] to 189 [38] participants) and were of low qual-
ity. None reported significant associations between
sodium intake and performance on these cognitive
domains (see Table 7).
DISCUSSION
This is the first review, to our knowledge, to synthe-
size the current evidence on the association between
sodium intake and cognitive outcomes. In total, fif-
teen studies were identified of which over 60% (n = 10
studies [27–31, 33, 34, 37, 40, 41]) reported signifi-
cant associations. However, mixed results were found
regarding whether dietary sodium intake is associated
with cognitive function. Of the eight studies with sig-
nificant results, five [27, 29, 30, 34, 40, 41] reported a
positive association, one reported a negative associa-
tion [31], one reported a mixed association [33], one
reported a j-shaped association [37], and the remain-
ing study reported that moderate sodium intake is
associated with cognitive impairment [28]. Even
though the overall evidence was mixed, higher quality
studies generally reported that lower sodium intake
was associated with better cognitive function [27,
29, 30]. A positive association between high sodium
intake and cognitive decline points to the possible
role of low sodium diets to prevent cognitive decline.
However, a lower sodium intake might also be asso-
ciated with poor cognitive performance which adds
to the complexity of this topic.
With regard to specific cognitive domains, there
appeared to be some evidence that high salt intake
is associated with poor global cognitive function
assessed using the MMSE/3MS. Indeed, four studies
[29, 30, 34, 40] reported a significant positive associ-
ation, one study [31] reported a significant negative
association, and two studies [37, 39] reported no asso-
ciation. In contrast, the results for memory, executive
function and processing speed, while mixed, gener-
ally reported no significant association. The three
studies with significant associations that assessed
global cognition were longitudinal in nature [29, 30]
and/or had large sample sizes (n = 1194 [29], n = 1262
[30], n = 925 [31]). The remaining two studies with
significant associations that assessed global cogni-
tion were cross-sectional with small sample sizes
(n = 119 [34], n = 44 [40]), but had significant risk-of-
bias issues. Of the six studies that examined memory
[35–38], executive functioning [27, 31, 35–37], and
processing speed [35, 38], only three studies reported
significant associations; one study for memory [37]
and two studies for executive functioning [27, 31].
Generally, the studies with significant associa-
tions were of low to intermediate risk-of-bias. These
studies also ranged from health community living
adults to more specific populations of higher risk
groups. For instance, Hwang et al.’s [37] study pop-
ulation comprised of heart failure patients which
can be considered a higher risk group due to the
cardio-metabolic risk being associated with dementia
[18–20]. This increases the chances of detecting a link
between sodium intake and cognitive function. Even
though the sample size in Hwang et al.’s study was
small (n = 91), statistically significant results were
still found in sodium intake’s relationship with mem-
ory. On the other hand, even if the study population
was of higher-risk, the limited spectrum of cognitive
function observed in a cross-sectional setting would
limit the chances of observing any significant associ-
ation. For example, in Bojar et al. [35], even though
participants were higher-risk (e.g., post-menopausal
women; defined as high risk given that a decline in
estrogen has been previously linked to increased risk
of cardiovascular diseases and dementia [42, 43]),
the results were null. This is likely because the study
only included participants on the higher spectrum
of cognitive performance (i.e., MoCA ≥ 26) and was
cross-sectional. More high-quality longitudinal stud-
ies in both healthy adults and high-risk groups across
wider cognitive spectrums are needed to illuminate
and test the mechanism of the sodium-cognition con-
tinuum.
With regard to incident MCI and dementia, the
results were mixed. In one study [28], moder-
ate sodium intake in hypertensive post-menopausal
women was found to be associated with an increased
risk of dementia (either alone or combined with
MCI). In another study, that focused on incident
dementia in healthy older adults, no association was
found [32]. The differing results may be due to study
population characteristics. For Haring et al. [28], the
study population comprised of only post-menopausal
women, and focused on hypertension as the main
exposure of interest. Li et al. [32] on the other hand,
focused on healthy men and women with sodium
intake as the exposure of interest.
The methods used for the analysis of the studies
may also have contributed to the differing results.
Haring et al. [28] performed separate analysis for
each strata of sodium levels, instead of conducting
analyses in the whole sample, reducing the statisti-
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cal power. In fact, to assess the association of sodium
and cognitive decline, it would have been more appro-
priate to use the sodium intake levels as a predictor
variable. In Li et al. [32], the follow up time was for
a sufficiently long period of time (36 years). How-
ever, the imprecise measurement of sodium intake
with just a single question (yes/no to whether the
participant was on a low-salt diet) at a single point
in time, may have affected the results. Analyses of
data from prospective studies with accurate assess-
ments of dietary sodium intake over time cognitive
status and dementia incidence are needed to confirm
whether excessive sodium consumption is associated
with impaired cognition and dementia risk.
To a certain extent, the findings from this review
support that higher sodium intake have bearings on
the cognitive health of middle and older aged individ-
uals. The missing link in all the studies included in
this review would be the inclusion of factors that may
allude to the different mechanisms of how sodium
intake affects cognition. So far, most studies that
adjusted for confounders typically targeted factors
associated with cardiometabolic health and inflam-
mation such as stroke, diabetes, hypertension or blood
pressure readings, and BMI. Given the potential
mechanism via a gut mediated pathway [17], it would
be interesting to observe the effects of sodium intake
and its interaction with cardiometabolic health and
inflammation (rather than just controlling for con-
founding) to also tease out the effects (if any) of the
gut mediated pathway hypothesis.
As the range of cognitive assessments is wide
and largely context dependent, more objective indi-
cations of cognitive function or decline should be
considered. Future studies can include cerebrospinal
fluid, neuroimaging, or blood biomarkers of dementia
and cognitive decline. There are robust biomark-
ers of dementia which are known to correlate with
pathological progression (especially in the case of
Alzheimer’s dementia) [44]. For example amyloid-
 levels and hippocampal volumes using magnetic
resonance imaging have been shown to have dif-
ferent trajectories across cognitive stages [45]. In
the case of vascular related dementia and cognitive
decline, neuroimaging and blood-based biomarkers
(inflammatory markers) may also have the potential
to further increase the accuracy of determining cogni-
tive status [46] and contributing to mechanism related
information.
This study has a number of strengths. To provide
a comprehensive and unbiased review of the existing
literature, a wider search strategy was used by includ-
ing studies with different designs (i.e., observational
and randomized clinical trials) and outcome measures
(i.e., cognitive function, cognitive decline, and inci-
dence of MCI and dementia). This approach also took
into consideration the limited number of studies pub-
lished in this area of research. Never the less, there
are some limitations. The included studies are char-
acterized by large heterogeneity in design, sampling
frame, cognitive assessment methods, assessment of
sodium intake, and analytical methods. This making
it difficult to compare results. Further, sodium intake
was mainly assessed using self-report tools including
FFQs [27–31, 38, 40], food diaries [27, 35–37, 39], or
a single question with binary responses probing the
individual level of sodium intake [32, 33, 41]. There-
fore, there is risk of under-reporting or over-reporting
and this could explain the lack of significant results
and the mixed unexplainable results. Only two studies
collected urine samples for objective measurement of
sodium excretion; one on a sub-set of participants
[28] and the other on total study population [34].
However, there are numerous difficulties with 24 h
urine collection including feasibility in population-
based setting, cost, and the need for logistical support
(i.e., storage and analysis). One option to increase
the validity and accuracy of FFQ would be to adjust
sodium levels derived from FFQs with sodium val-
ues from 24 h urine samples collection from a subset
of the study population. This is similar to the meth-
ods used by Haring et al. [28]. In that way, less
resources would be used, yet the study would have
a more accurate estimation of sodium intake from
the adjustment. Last, only studies in English were
included. Only seven studies [47–53] were excluded
based on this criterion. Moreover, one of the results
of the excluded study (from the abstract which was in
English) alluded to the association of dementia with
high-salt diet [47]. The other six non-English articles
(abstracts were in English) also fit other exclusion
criteria (five studies did not measure cognition and/or
sodium intake levels [48, 49, 51–53], one study was
a review [50]) that were set for this study. Therefore,
the exclusion of the non-English articles was unlikely
to influence the overall interpretation and validity of
the results.
Conclusions
The studies in this review reported heterogeneous
findings on the association between sodium con-
sumption and cognitive function in humans. Overall,
the strength of the evidence is modest, which could
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be largely attributed to between-study differences in
design, dietary, analytical, and cognitive assessment
methods. Robust longitudinal analyses are needed to
evaluate the association of different levels of sodium
intake with cognitive decline to minimize the poten-
tial influence of residual confounding and reverse
causality on the associations. Different target popu-
lations are needed including people with and without
chronic vascular related conditions such as hyperten-
sion, heart disease, or kidney disease, to the add to the
evidence base on the possible mechanisms on how the
sodium-cognition pathway works, e.g., the gut medi-
ated or vascular inflammatory pathway. The results
from these further studies can then inform the design
of targeted sodium-reducing nutritional and lifestyle
interventions.
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